Skip to main content
. 1998 Sep;72(9):7263–7269. doi: 10.1128/jvi.72.9.7263-7269.1998

TABLE 1.

Summary of EIAV-infected horses, clinical parameters, and plasma viremia

Horse no. Virus strain Virus dosea Initial clinical diseaseb Days postinfection at necropsy Clinical status at necropsy Viremia during acute diseasec
2084 Wyo 106 Severe 15 Acute clinical Yes
2092 Wyo 101 Severe 22 Acute clinical Yes
2079 WSU5 106 Mild 29 Acute clinical Yes
2085 Wyo 106 Severe 124 Chronic clinical Yes
524 Wyo 103 Severe 879 Subclinical Yes
489 WSU5 106 Mild 665 Subclinical Yes
498 WSU5 106 Mild 726 Subclinical Yes
a

EIAVWyo, horse infectious doses; EIAVWSU5, 50% tissue culture infectious doses. 

b

Severe disease characterized by evidence of hemorrhagic diathesis. 

c

Virus was detected by RT-PCR on plasma and/or virus isolation on neonatal equine kidney cells.